India may soon have at least a couple of options for adolescent Covid-19 vaccines, if things go well.
One of the prime contenders is the Zydus Cadila DNA-plasmid vaccine which has held trials on children aged 12 years and above, and one could be a foreign vaccine – either Pfizer-BioNTech or Moderna’s mRNA vaccine – if the legal issues are sorted out soon. Indigenous vaccine maker Bharat Biotech’s inactivated whole virus vaccine is now undergoing trials on children aged two years or more. However, there is time till it is approved and available in the market. One can expect the